Sestrin2 inhibits RANKL-induced osteoclastogenesis through AMPK activation and ROS inhibition.

MLA

Kim, Kabsun, et al. “Sestrin2 Inhibits RANKL-Induced Osteoclastogenesis through AMPK Activation and ROS Inhibition.” Free Radical Biology & Medicine, vol. 211, Feb. 2024, pp. 77–88. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2023.12.009.

APA

Kim, K., Kim, J. H., Kim, I., Seong, S., Koh, J.-T., & Kim, N. (2024). Sestrin2 inhibits RANKL-induced osteoclastogenesis through AMPK activation and ROS inhibition. Free Radical Biology & Medicine, 211, 77–88. https://doi.org/10.1016/j.freeradbiomed.2023.12.009

Chicago

Kim, Kabsun, Jung Ha Kim, Inyoung Kim, Semun Seong, Jeong-Tae Koh, and Nacksung Kim. 2024. “Sestrin2 Inhibits RANKL-Induced Osteoclastogenesis through AMPK Activation and ROS Inhibition.” Free Radical Biology & Medicine 211 (February): 77–88. doi:10.1016/j.freeradbiomed.2023.12.009.